Log In
Print
BCIQ
Print
Print this Print this
 

UX003

  Manage Alerts
Collapse Summary General Information
Company Ultragenyx Pharmaceutical Inc.
DescriptionRecombinant human glucuronidase beta (GUSB)
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentPreclinical
IndicationMucopolysaccharidosis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today